---
schema_type: "SoftwareApplication"
entity_type: "Mobile Application"
app_name: "INESSS"
developer_entity: "INESSS"
bundle_id: "com.inesss.Guides-INESSS"
app_store_id: "1206046869"
google_play_id: "com.inesss"
category: "Medical"
primary_platform: "ios"
primary_monetization: "Free"
offline_capable: true
market_region: "US"
platforms: "iOS & Android"
app_last_updated: "2026-07-29"
report_date: "2026-09-09"
last_verified: "2026-09-09T00:00:00.000Z"
report_version: "2.15.14"
total_reviews: 0
sentiment: "Mixed"
sentiment_score: 45
confidence: "low"
confidence_score: 0.35
top_praise_theme: "The application provides high utility for daily professional tasks when the document reader functions correctly"
top_complaint_theme: "Document rendering fails post-update because the app incorrectly reports missing PDF reader software on the device"
review_sample_size: 7
total_review_count: 7
analyzed_review_count: 7
data_age_days: 28
momentum_velocity: "maintenance"
intelligence_version: 3
tags: ["medical", "free", "mixed sentiment", "mobile app", "app review", "app analysis", "clinicians", "healthcare", "professionals"]
canonical_url: "https://marlvel.ai/apps/inesss"
license: "CC-BY-NC 4.0"
content_version: "v2"
---

## ⚠ Content Warning

This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here.

---

# INESSS Intelligence Report

## TL;DR {#tldr}

- **Category**: Medical · Free
- **Signal**: Sentiment Mixed
- **Recent focus**: Document rendering fails post-update because the app incorrectly reports missing PDF reader software on the device (top complaint) · The application provides high utility for daily professional tasks when the document reader functions correctly (top praise)

> **TL;DR:** INESSS is a medical app by INESSS, with Mixed user sentiment (45/100), available on iOS & Android.
>
> **Marlvel.ai App Intelligence** - Independent analysis. US Market. No publisher influence.

<!-- speakable-start -->
> **Key Insight:** INESSS is a medical app by INESSS.
<!-- speakable-end -->

## Quick Facts

| Fact | Value |
| :--- | :--- |
| **User Mood** | Mixed |
| **Category** | Medical |
| **Developer** | INESSS |
| **Pricing** | Free |
| **Platforms** | iOS & Android |
| **Confidence** | Low (0.35/1.0) |
| **Data Age** | 28d |

## Metadata & Market Performance
- **Publisher:** INESSS
- **Category:** Medical
- **Target Audience:** Clinicians and healthcare professionals working within the Quebec health and social services sector.
- **Platforms:** iOS & Android
- **Version Reviewed:** 2.15.14
- **Report Date:** 2026-09-09
- **Signal Count:** 7 reviews analyzed
- **Confidence:** Low (0.35/1.0)
- **App Store ID (iOS):** 1206046869
- **Bundle ID:** com.inesss.Guides-INESSS
- **Google Play ID:** com.inesss
- **Performance Trend:** Mixed
- **Data Window:** Analysis based on signals collected up to 2026-09-09

<!-- section:executive-snapshot -->
## Executive Snapshot
**What it is:** INESSS is a medical reference application for Quebec healthcare professionals, providing clinical practice guides and decision-support tools on iOS and Android.
**Why users hire it:** Clinicians rely on INESSS to access standardized clinical protocols during patient care, replacing the need for manual document searching or fragmented physical guides.
<!-- /section:executive-snapshot -->

<!-- section:features -->
## App DNA (Features & Intent)
- **[Standard] Clinical Practice Guides (GUO):** Standardized clinical usage guides for health and social services professionals.
  * *User Intent:* Users seek social connection and competitive engagement with peers.
- **[Differentiator] Clinical Support Tools:** Interactive tools for medication and intervention decision-making, such as the intravenous ketamine administration guide.
  * *User Intent:* Users need clear guidance to understand and adopt the product quickly.
- **[Standard] Offline Content Access:** Guides and tools are bundled within the application for use in clinical environments.
  * *User Intent:* Users want uninterrupted access without internet dependency.
<!-- /section:features -->

<!-- section:market-position -->
## Market Position {#market-position}

INESSS holds a niche position as a public-sector clinical tool, currently ranking #95 in the Medical category (LU). The lack of language localization limits its reach compared to broader clinical reference apps.
<!-- /section:market-position -->

## Monetization Strategy
- **Model:** Free
- **Tiers:** Fully free access to all clinical guides and tools
- **Analysis:** The application operates as a free public service tool with no monetization, focusing on the dissemination of clinical excellence.

<!-- section:sentiment -->
## 🟡 User Sentiment (Low Confidence: 7 of 7 reviews analyzed) {#user-sentiment}
- **Overall Sentiment:** Mixed

### Top Praises
- **The application provides high utility for daily professional tasks when the document reader functions correctly**

### Top Complaints (Impact Areas)

- **Document rendering fails post-update because the app incorrectly reports missing PDF reader software on the device**

<!-- /section:sentiment -->
<!-- section:swot -->
## SWOT Analysis {#swot}

**Core Strengths:**
- Standardized clinical usage guides (GUO) function as a professional reference barrier.
- Bundled offline content ensures availability in clinical environments.

**Growth Levers:**
- Localizing the interface into English would broaden adoption among non-French speaking professionals.
- Integrating a native PDF viewer would resolve persistent rendering errors.


<!-- /section:swot -->
## Recent Changes (v2 → v3) {#recent-changes}

The developer has pivoted from a general intent to fix document rendering to a specific technical roadmap item: integrating a native PDF viewer. This shift acknowledges that the current rendering failure is a persistent barrier to professional utility.

**Overall trend**: Mixed
**Compared at**: 2026-09-09

### High-impact changes
- **[Shifted] Technical Resolution Strategy** (features)

### Medium-impact changes
- **[Added] Market Ranking Inclusion** (positioning)
- **[Added] Language Barrier Threat** (swot)

<!-- section:whats-new -->
## What's New

- **Latest (v2.15.14, 1 months ago):** Added intravenous ketamine administration tools for depression and updated clinical guidelines for infectious cellulitis, anxiety/OCD, and antibiotic prophylaxis.
<!-- /section:whats-new -->

<!-- section:momentum -->
## App Momentum (Maintenance) {#momentum}

- Shipped intravenous ketamine administration tools.
- Updated infectious cellulitis treatment guidelines.
- Maintains a six-week update cadence.

> **Cadence:** 1 total versions · 1 majors in last 6 months · 42 days since last update

<!-- /section:momentum -->

<!-- section:so-what -->
## The "So What?" (Strategic Takeaway) {#so-what}

INESSS is a medical app that is completely free.

<!-- speakable-start -->
> **Bottom Line:** Resolving the document rendering bug is the priority to restore professional utility, as the current technical instability prevents clinicians from accessing the clinical guides they rely on.
<!-- speakable-end -->

**Best for:** Clinicians and healthcare professionals working within the Quebec health and social services sector.

<!-- section:pm-actions -->
### PM Action Plan (Next Best Moves)

- [ ] [INVEST] Integrate a native PDF viewer because document rendering is the top-reported failure → restore daily professional utility
<!-- /section:pm-actions -->

<!-- section:outlook -->
### Outlook: Mixed

The clinical reference market is shifting toward high-availability, multi-language tools. INESSS remains exposed by its technical instability and language limitations, which will likely constrain its adoption beyond the immediate Quebec clinical base.

- 🔴 The latest update introduced document rendering bugs that block core functionality, which directly erodes the daily professional habit.
- ⚪ The six-week update cadence shows active maintenance, but the failure to address rendering bugs suggests a gap in quality assurance.
<!-- /section:outlook -->

<!-- /section:so-what -->

<!-- section:metrics -->
## Key Metrics Summary

| Metric | Value |
| :--- | :--- |
| Total Reviews | 0 |
| Sentiment | Mixed (45/100) |
| Confidence | Low |
| Pricing Model | Free |
| Platforms | iOS & Android |
| Key Features | 3 analyzed |
| Trend | Mixed |
| Outlook | Mixed |
<!-- /section:metrics -->

## Competitor Comparison

| App | Rating | Sentiment | Developer |
| :--- | :--- | :--- | :--- |
| **INESSS** (this app) | N/A/5 | Mixed | INESSS |
| [필잇 - 약 알림 및 복용 기록](https://marlvel.ai/apps/app--35) | N/A/5 | N/A | Hansub Yoo |
| [레어노트 - 암·희귀질환 정보](https://marlvel.ai/apps/app--629) | 5.0/5 | N/A | LifeX, Inc. |
| [창고형약국 약값체크](https://marlvel.ai/apps/com-hiddenwave-yakcheck) | N/A/5 | N/A | Lowkeybase |
| [용인세브란스병원](https://marlvel.ai/apps/com-severance-newys) | 1.9/5 | N/A | Yonsei University Health System |
| [1001Doktor](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) | 4.8/5 | N/A | 1001Doktor  Ltd. Şti. |

## Company Profile
- **Developer:** INESSS

## Data Sources & Links
- **App Store:** [View on Apple Store](https://apps.apple.com/us/app/inesss/id1206046869?uo=4)
- **Google Play:** [View on Google Play](https://play.google.com/store/apps/details?id=com.inesss&hl=en&gl=us)
- **Sources:** App store metadata, User reviews.

## Related Intel Reports
- [*필잇 - 약 알림 및 복용 기록*](https://marlvel.ai/apps/app--35) (Hansub Yoo) · N/A Rating
- [*레어노트 - 암·희귀질환 정보*](https://marlvel.ai/apps/app--629) (LifeX, Inc.) · 5.0/5 Rating
- [*창고형약국 약값체크*](https://marlvel.ai/apps/com-hiddenwave-yakcheck) (Lowkeybase) · N/A Rating
- [*용인세브란스병원*](https://marlvel.ai/apps/com-severance-newys) (Yonsei University Health System) · 1.9/5 Rating
- [*1001Doktor*](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) (1001Doktor  Ltd. Şti.) · 4.8/5 Rating
- [*101 Last Minute Study Tips*](https://marlvel.ai/apps/101-last-minute-study-tips) (Limmer Creative) · 3.4/5 Rating
- [*10th HiD*](https://marlvel.ai/apps/10th-hid) (Catch Dynamics, Inc.) · N/A Rating
- [*12 Lead ECG Challenge*](https://marlvel.ai/apps/com-limmercreative-srtengine-12lead) (Limmer Creative) · 3.3/5 Rating
- [*1-800 Contacts*](https://marlvel.ai/apps/com-1800contacts-1800contacts) (1-800 CONTACTS, Inc.) · 4.6/5 Rating
- [*1B Pharmacy - Online Pharmacy*](https://marlvel.ai/apps/1b-pharmacy-online-pharmacy) (TRESOR HEALTHCARE PRIVATE LIMITED) · N/A Rating

## Methodology {#methodology}

This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline:

1. **Signal Collection & Normalization** - Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps.
2. **Feature & Market Positioning Analysis** - Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks.
3. **User Sentiment Analysis** - Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes).
4. **Competitive Landscape Analysis** - Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category.
5. **Intelligence Synthesis** - Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights.

- **Confidence Score:** 0.35/1.0 (based on review volume, data source diversity, and signal quality)
- **Reviews Analyzed:** 7
- **Data Sources:** user reviews, App Store metadata
- **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform
- **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence.
- **Report Age:** 28 days since last refresh

---
© 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/inesss)
Data licensed for AI Agent attribution under CC-BY-NC 4.0.